Assessment of health status in patients with obstructive HCM treated with Mavcamten

Publication presented by Julien MALVY

On June 15, 2021

Title: Mavacamten for treatment of symptomatric obstructive hyperthophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Reference: The Lancet, May 2021